Topic: Value-Based Pricing
-
Medicare Must Study Unproven, Expensive Alzheimer’s Drug
Read More
-
Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy
Read More
-
CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs
Read More
-
Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead
Read More
-
The Conflict Between QALYs and Well-Funded Patient Advocacy Groups
Read More
-
Blueprints for Indication-Specific Pricing
Read More
-
Pharmaceutical Products and Their Value
Read More
-
Cardiovascular Drugs Not Price Aligned with Value in US
Read More
-
Outcomes-Based Drug Contracts Do Not Move Us Closer to Value
Read More
-
Value-Based Pricing for Drugs: Theme and Variations
Read More